Skip to content

A comparison of nebulized 3% hypertonic saline and epinephrine versus nebulized normal saline and epinephrine in the treatment of acute bronchiolitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN66632312
Enrollment
46
Registered
2005-09-13
Start date
2004-02-14
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis Respiratory Bronchiolitis

Interventions

Patients who entered the study were randomized to receive either nebulized epinephrine in hypertonic saline or nebulized epinephrine in normal saline. Each patient had his or her oxygen saturation lev

Sponsors

University of Alberta, Department of Pediatrics (Canada)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Infants 6 weeks to 12 months of age with clinical symptoms of a viral respiratory infection (coryza or temperature = 38.0°C), first episode of wheezing, oxygen saturation = 85% but = 96%, and initial Respiratory Distress Assessment Instrument (RDAI) score = 4.

Exclusion criteria

Exclusion criteria: Pre-existing cardiac or pulmonary disease, previous diagnosis of asthma by a physician, any previous use of bronchodilators, severe disease requiring resuscitation room care, inability to administer medication by nebulizer, inability to obtain informed consent secondary to a language barrier, or no phone access for follow-up.

Design outcomes

Primary

MeasureTime frame
The Respiratory Assessment Change Score (RACS) was the primary outcome variable of the study. This score is a clinical scoring system based on the Respiratory Distress Assessment Index (RDAI) and the respiratory rate.

Secondary

MeasureTime frame
Oxygen saturation and rate of admission to hospital.

Countries

Canada

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026